Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CUE-101 |
Trade Name | |
Synonyms | CUE101|CUE 101|anti-HPV16 E7 fusion protein CUE-101 |
Drug Descriptions |
CUE-101 is a fusion protein consisting of an HLA-A*0201 complex linked to an HPV16 E7 epitope (aa 11-20), a reduced affinity version of interleukin-2, and an effector attenuated IgG1 Fc domain, which binds to HPV16 E7-specific T-cells, potentially activating a T-cell response against HPV16 E7-positive tumor cells (PMID: 31964784). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C162459 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CUE-101 | CUE-101 | 0 | 2 |
CUE-101 + Pembrolizumab | CUE-101 Pembrolizumab | 0 | 1 |